Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 83851-83900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05366166
Pembrolizumab Plus Olaparib in LA-HNSCC
PHASE2Recruiting
45 participants
Started: Sep 2, 2022 · Completed: Oct 31, 2026
1 condition2 sponsors4 locations
NCT05717959
Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device
NARecruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05480982
Cognitive Functional Therapy Compared With Pilates in Elderly Patients With Chronic Low Back Pain
NARecruiting
200 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05496959
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
PHASE2Active, not recruiting
93 participants
Started: Sep 2, 2022 · Completed: Sep 1, 2033
4 conditions2 sponsors1 location
NCT06027567
The Effect of an Anti-obesity Drug, Semaglutide, As Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (dietician) with Regards to Change in Weight and Intracranial Pressure
PHASE4Active, not recruiting
50 participants
Started: Sep 2, 2022 · Completed: Oct 30, 2025
6 conditions4 sponsors2 locations
NCT05925218
Circulating Tumor DNA Collection From Patients With High Grade Gliomas
N/ARecruiting
70 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05214222
Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma
PHASE2Recruiting
100 participants
Started: Sep 2, 2022 · Completed: Sep 2, 2028
1 condition1 sponsor1 location
NCT05366179
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PHASE1Recruiting
36 participants
Started: Sep 2, 2022 · Completed: May 30, 2030
1 condition1 sponsor1 location
NCT06726850
Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.
PHASE2Recruiting
129 participants
Started: Sep 2, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05398627
Neurofeedback for Borderline Personality Disorder
NAActive, not recruiting
100 participants
Started: Sep 2, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT03810768
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
N/ARecruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2026
7 conditions4 sponsors3 locations
NCT05212272
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
NARecruiting
16 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05824871
A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
PHASE3Recruiting
450 participants
Started: Sep 2, 2022 · Completed: Oct 22, 2026
2 conditions1 sponsor2 locations
NCT03824106
Frailty Rehabilitation
NARecruiting
324 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06116240
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
135 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor12 locations
NCT07024667
Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy
NARecruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05339698
3D Evaluation to Quantify Regional Volume Change Between FRC and TLC
N/ARecruiting
100 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06267781
RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies
N/ARecruiting
30 participants
Started: Sep 2, 2022 · Completed: Sep 2, 2027
1 condition1 sponsor1 location
NCT05624658
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
NARecruiting
200 participants
Started: Sep 2, 2022 · Completed: May 31, 2024
1 condition2 sponsors1 location
NCT05530551
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
NAActive, not recruiting
20,000 participants
Started: Sep 1, 2022 · Completed: Mar 1, 2025
3 conditions7 sponsors36 locations
NCT05094570
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
PHASE4Recruiting
20 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05488353
A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma
PHASE4Not yet recruiting
48 participants
Started: Sep 1, 2022 · Completed: Apr 30, 2026
1 condition5 sponsors0 locations
NCT05151965
Return to Sport and Functional Performance Following Surgical Intervention for Anterior Glenohumeral Instability
N/ARecruiting
72 participants
Started: Sep 1, 2022 · Completed: Apr 1, 2026
2 conditions1 sponsor1 location
NCT05270902
Haemoadsorption During Heart Transplantation
NARecruiting
40 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05619068
The Evolution and Prognosis of Moyamoya Disease
N/ARecruiting
300 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT06677866
Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder
NARecruiting
20 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05515796
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
PHASE2Recruiting
200 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT05499949
The Franciscus Obesity NASH Study
N/AActive, not recruiting
300 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2029
3 conditions4 sponsors1 location
NCT05968729
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
NARecruiting
40 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT06163612
Effect of Suicidality on Social Cognition
N/ARecruiting
150 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05522426
Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting
NAActive, not recruiting
50 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT04271332
Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion
PHASE2Active, not recruiting
60 participants
Started: Sep 1, 2022 · Completed: Mar 23, 2025
1 condition1 sponsor4 locations
NCT05673941
"InMotion - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia"
NAActive, not recruiting
60 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05317221
Developing Breast (Cancer) Organoids
N/ARecruiting
60 participants
Started: Sep 1, 2022 · Completed: May 1, 2028
1 condition3 sponsors1 location
NCT05533892
Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC
PHASE1Recruiting
30 participants
Started: Sep 1, 2022 · Completed: Feb 28, 2025
1 condition10 sponsors1 location
NCT06175416
Spontaneous Pneumothorax in Adolescents
N/ARecruiting
134 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05521022
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
PHASE1Recruiting
100 participants
Started: Sep 1, 2022 · Completed: Mar 1, 2025
1 condition2 sponsors11 locations
NCT05545228
The Mouth Matters in Mental Health Study
NAActive, not recruiting
79 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2024
1 condition1 sponsor5 locations
NCT05432687
Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)
NARecruiting
80 participants
Started: Sep 1, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05445349
Breathing Parameter Measurements for Lung Deposition Simulation
N/AActive, not recruiting
163 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2025
2 conditions7 sponsors3 locations
NCT05585255
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
N/ARecruiting
108 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2024
3 conditions1 sponsor2 locations
NCT05712447
Duchenne Muscular Dystrophy Video Assessment Registry
N/AActive, not recruiting
180 participants
Started: Sep 1, 2022 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT05377216
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
EARLY_PHASE1Recruiting
20 participants
Started: Sep 1, 2022 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT05344716
FotonaSmooth Erbium:YAG Laser for the Treatment of Urethral Pain Syndrome in Women
NARecruiting
30 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05432999
Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury
NARecruiting
30 participants
Started: Sep 1, 2022 · Completed: Feb 1, 2026
7 conditions1 sponsor1 location
NCT06446778
Pipeline Embolization for Intracranial Aneurysms
N/ARecruiting
1,000 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2030
4 conditions13 sponsors1 location
NCT05862389
Study on the Mechanism of Eating Disorder
N/ARecruiting
750 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT04732052
The Use of Transcranial Direct Current Stimulation (tDCS) in Adults With Developmental Disabilities
NARecruiting
60 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03274869
Scrub Typhus Infection Induced Cardiovascular Disease
N/AActive, not recruiting
100 participants
Started: Sep 1, 2022 · Completed: Aug 30, 2027
2 conditions3 sponsors2 locations
NCT05520983
BEhavioral Health Stratified Treatment (BEST) Study for Youth With Intellectual and/or Developmental Disabilities (IDD)
NAEnrolling by invitation
780 participants
Started: Sep 1, 2022 · Completed: Jan 1, 2028
3 conditions5 sponsors1 location